Adjuvant therapy

MammaPrint and BluePrint as prognostic indicators for elderly patients with early-stage breast cancer

PUBLICATION: SABCS 2020 AUTHORS: Peter W. Blumencranz, Mehran Habibi, Read More

2024-03-25T08:05:58-04:00December 29th, 2020|Adjuvant, Evidence, MINT, Neoadjuvant|

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial

PUBLICATION: European Journal of Cancer AUTHORS: Valesca P. Retel, Read More

2024-03-25T11:21:54-04:00September 1st, 2020|Adjuvant, Evidence, Healthcare Economics, MINDACT, Other|
Go to Top